Department of General Surgery, Ochsner Clinical School, The University of Queensland School of Medicine, 1514 Jefferson Highway, New Orleans, LA, 70121, USA.
Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, USA.
Surg Endosc. 2018 Feb;32(2):977-982. doi: 10.1007/s00464-017-5775-7. Epub 2017 Aug 4.
Gastroparesis is difficult to treat and many patients do not report relief of symptoms with medical therapy alone. Several operative approaches have been described. This study shows the results of our selective surgical approach for patients with gastroparesis.
This is a retrospective study of prospective data from our electronic medical record and data symptom sheet. All patients had a pre-operative gastric emptying study showing gastroparesis, an esophagogastroduodenoscopy, and either a CT or an upper GI series with small bowel follow-through. All patients had pre- and post-operative symptom sheets where seven symptoms were scored for severity and frequency on a scale of 0-4. The scores were analyzed by a professional statistician using paired sample t test.
58 patients met inclusion criteria. 33 had gastric stimulator (GES), 7 pyloroplasty (PP), 16 with both gastric stimulator and pyloroplasty (GSP), and 2 sleeve gastrectomy. For patients in the GSP group, the second procedure was performed if there was inadequate improvement with the first procedure. There was no mortality. The follow-up period was 6-316 weeks (mean 66.107, SD 69.42). GES significantly improved frequency and severity for all symptoms except frequency of bloating and postprandial fullness. PP significantly improved nausea and vomiting severity, frequency of nausea, and early satiety. Symptom improvement for GSP was measured from after the first to after the second procedure. GSP significantly improved all but vomiting severity and frequency of early satiety, postprandial fullness, and epigastric pain.
All procedures significantly improved symptoms, although numbers are small in the PP group. GES demonstrates more improvement than PP, and if PP or GES does not adequately improve symptoms GSP is appropriate. In our practice, gastrectomy was reserved as a last resort.
胃轻瘫难以治疗,许多患者仅接受药物治疗无法缓解症状。已经描述了几种手术方法。本研究展示了我们对胃轻瘫患者的选择性手术方法的结果。
这是对我们电子病历和数据症状表中前瞻性数据的回顾性研究。所有患者均进行了术前胃排空研究,显示胃轻瘫,食管胃十二指肠镜检查,以及 CT 或上消化道系列检查,包括小肠跟踪检查。所有患者均进行了术前和术后症状表评估,其中七个症状的严重程度和频率分别按 0-4 分进行评分。分数由专业统计员使用配对样本 t 检验进行分析。
58 名患者符合纳入标准。33 名患者接受了胃刺激器(GES)治疗,7 名患者接受了幽门成形术(PP),16 名患者接受了胃刺激器和幽门成形术(GSP)联合治疗,2 名患者接受了袖状胃切除术。对于 GSP 组的患者,如果第一次手术效果不理想,则进行第二次手术。无死亡病例。随访时间为 6-316 周(平均 66.107,SD 69.42)。GES 显著改善了所有症状(除腹胀和餐后饱胀的频率外)的严重程度和频率。PP 显著改善了恶心和呕吐的严重程度、恶心的频率以及早饱。GSP 的症状改善是从第一次手术后到第二次手术后测量的。GSP 显著改善了除呕吐严重程度和早饱、餐后饱胀和上腹痛的频率外的所有症状。
所有手术均显著改善了症状,尽管在 PP 组中数量较少。GES 比 PP 显示出更多的改善,如果 PP 或 GES 不能充分改善症状,则适合采用 GSP。在我们的实践中,胃切除术是最后的手段。